variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
ABCA4-P1780A,ABCA4,"Reported to have caused Stargardt disease (progressive vision loss and blindness) in a recessive manner when seen in a single compound heterozygous case, but insufficient data makes it impossible to determine the significance of this report.",High,Uncertain,Pathogenic,0.00037,Hearing and vision,Recessive,Heterozygous,10746567,rs121909207,5,chr1,94480221,C,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
LRP5-V667M,LRP5,"This variant has been implicated in causing osteoporosis-pseudoglioma syndrome in a recessive manner. The gene is strongly implicated in causing the disease, but an insufficient number of controls means this variant's observation lacks statistical significance. The condition manifests in childhood with early onset osteoporosis and eye problems.",High,Uncertain,Pathogenic,0.041,"Hearing and vision;Muscular, skeletal, and connective tissue",Recessive,Heterozygous,11719191,rs4988321,5,chr11,68174189,A,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
C3-R102G,C3,"This variant (also called C3F) is common in Europeans (10.2% allele frequency), and is associated with age-related macular degeneration. In the US, 1.5% of adults over 40 have the disease, but the incidence increases strongly with age (>15% in women over 80). Assuming an average lifetime risk of ~10%, heterozygous individuals have a ~13% risk and homozygous have ~20%.",Moderate,Likely,Pathogenic,0.15,Hearing and vision,Complex/Other,Heterozygous,4427677;17634448,rs2230199,3,chr19,6718387,C,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
COL4A1-Q1334H,COL4A1,"This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.",Low,Likely,Pathogenic,0.32,Heart and circulatory,Dominant,Heterozygous,10334796;18077766;20031579,rs3742207,2,chr13,110818598,G,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Homozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
PRF1-A91V,PRF1,"This variant may be associated with a slightly increased susceptibility to some rare blood disorders, in particular autoimmune proliferative disease, if combined with a more severe mutation elsewhere. Most reports lack statistical significance.",Low,Likely,Pathogenic,0.033,Blood;Immune system,Complex/Other,Heterozygous,16720836;17311987;17475905,rs35947132,1,chr10,72360387,A,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
rs5186,,"This common noncoding genetic variant has an allele frequency of ~30% and is associated with an increased risk of hypertension. If ~25% of non-carriers have hypertension, Bonnardeaux et al's data predict ~4% increased risk of hypertension per copy of this variant. This SNP is in the 3' noncoding region of the AGTR1 transcript (angiotensin II type 1 receptor), also known as AT2R1 or AT1R, which is a target of hypertension drugs.",Low,Likely,Pathogenic,0.21,Drug response;Heart and circulatory,Unknown,Homozygous,"8021009;
11250978;11593098;16046653;16675453;17668390",rs5186,2,chr3,148459988,C,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
SCNN1G-E197K,SCNN1G,"May cause slight increased risk of rare, CFTR-like disease.",Low,Uncertain,Pathogenic,0.0064,Other,Dominant,Heterozygous,18507830;19462466,rs5738,1,chr16,23200963,A,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
RNASEL-R462Q,RNASEL,"Associated with increased risk of prostate cancer in individuals who already have a family history of prostate cancer, but studies have been unable to replicate this finding in sporadic (non-familial) prostate cancer cases.",Low,Uncertain,Pathogenic,0.28,Cancer;Genital and urinary,Complex/Other,Heterozygous,11941539;12022038;12415269;17407163,rs486907,2,chr1,182554557,T,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
LRP5-A1330V,LRP5,"In a study of a UK population this variant was associated with a small increased risk of osteoporosis and osteoporotic bone fractures, with each copy of the variant presumed to have an additive effect. A study in Chinese young men failed to find an association with peak bone density.

 
",Low,Uncertain,Pathogenic,0.11,"Muscular, skeletal, and connective tissue",Complex/Other,Heterozygous,18455228;19148563;20953208,rs3736228,2,chr11,68201295,T,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Heterozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
CLEC7A-Y238X,CLEC7A,This variant has been found to impair homan mucosal antifungal defense and was implicated in vulvovaginal candidiasis and mucocutaneous infections in a Dutch family.,Low,Uncertain,Pathogenic,0.063,Genital and urinary;Skin,Recessive,Heterozygous,19864674,rs16910526,4,chr12,10271087,C,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Heterozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
ITPA-P32T,ITPA,"This variant is associated with inosine triphosphate pyrophosphohydrolase deficiency and may be associated with an adverse reaction to thiopurine drugs (which are used as immunosuppressants). Homozygotes have no detectable ITPase activity, individuals compound heterozygous with another less severe mutation also have severely reduced enzyme activity.",Low,Well-established,Pharmacogenetic,0.061,Drug response;Immune system;Metabolism,Recessive,Heterozygous,12384777;15322947;17924837;19631656;19682085;20173735,rs1127354,1,chr20,3193842,A,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
ABCC6-R1268Q,ABCC6,This common polymorphism appears to not have a significant phenotypic impact. A few studies report weak but significant associations with plasma lipids (in Inuits) and thalidomide toxicity.,Low,Uncertain,Pharmacogenetic,0.22,Metabolism,Unknown,Heterozygous,10811882;10913334;11776382;20038957,rs2238472,1,chr16,16251599,T,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
rs1544410,,"rs1544410 is a Vitamin D Receptor (VDR) single nucleotide polymorphism. It is unlikely that it has functional significance because it is located in an intron (Liu et. al.), but it is in strong linkage disequilibrium with rs731236 (Dvornyk et al), which is located in an exon. ",Low,Uncertain,Pharmacogenetic,0.35,Other,Unknown,Heterozygous,,rs1544410,0,,,,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
FUT2-W154X,FUT2,"This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are ""non-secretors"": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.",Moderate,Well-established,Protective,0.49,Blood;Immune system,Recessive,Heterozygous,7876235;12692541;19625485;20031047;22025362,rs601338,5,chr19,49206674,A,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
PRNP-M129V,PRNP,"This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.

",Low,Well-established,Protective,0.34,Other,Complex/Other,Heterozygous,18236005;19081515,rs1799990,0,chr20,4680251,G,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
NPC1-H215R,NPC1,"This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6"" individual).





",Low,Likely,Protective,0.3,Metabolism,Complex/Other,Homozygous,19151714;19174833;19910939,rs1805081,2,chr18,21140432,C,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
IL7R-T244I,IL7R,"The reference genome variant for this allele has been associated with a slight increased risk of multiple sclerosis. Thus, this variant can be treated as a ""protective"" variant -- carriers of this variant are slightly less likely to have MS. Because the disease is rare and the effect of this variant is not very strong, the absolute decreased risk for carriers of this variant is less than .05% (less than 1 in 2000).",Low,Likely,Protective,0.21,Immune system;Nervous system,Unknown,Heterozygous,12825072;17660530;17660816;17660817;21161391,rs6897932,0,chr5,35874575,T,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
TTR-T139M,TTR,"This variant is reported to have a protective effect in carriers of the V30M variant in this gene -- V30M causes familial amyloidosis, but this variant appears to protect against that pathogenic effect.",Low,Uncertain,Protective,0.0024,Metabolism,Dominant,Heterozygous,8064809;11577236,rs28933981,1,chr18,29178610,T,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
TGFB1-T263I,TGFB1,Carriers may be less likely to have cleft lip and palate congenital deformity.,Low,Uncertain,Protective,0.021,Anatomical and congenital,Dominant,Heterozygous,15212689,rs1800472,0,chr19,41847860,A,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
EFHC1-R182H,EFHC1,Probably benign. OMIM appears to incorrectly interpret literature as linking this variant to juvenile myoclonic epilepsy; the authors report it as a polymorphism.,Low,Likely,Benign,0.044,Nervous system,Unknown,Heterozygous,7668263;15258581,rs3804505,,chr6,52303361,A,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
PMS2-P470S,PMS2,"Benign, common variant.",Low,Likely,Benign,0.37,Other,Unknown,Homozygous,15256438,rs1805321,,chr7,6026988,A,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
CACNA1S-L458H,CACNA1S,Common polymorphism,Low,Likely,Benign,0.27,Other,Unknown,Heterozygous,,rs12742169,,chr1,201052310,T,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
FANCA-M717I,FANCA,"Rare polymorphism, not considered pathogenic.",Low,Likely,Benign,0.022,Other,Unknown,Heterozygous,10521298,rs1131660,,chr16,89838086,A,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
RPGRIP1-A547S,RPGRIP1,"Probably benign. Implicated in causing autosomal recessive cone-rod dystrophy, but a later report found the same incidence in controls and concludes it is not causal.",Low,Uncertain,Benign,0.23,Hearing and vision,Complex/Other,Heterozygous,12920076;16272259,rs10151259,,chr14,21790040,T,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
BRCA1-R1347G,BRCA1,"Believed to be a nonpathogenic polymorphism, although Polyphen 2 predicts a damaging effect.",Low,Uncertain,Benign,0.0043,Other,Unknown,Heterozygous,8776600;12215251,rs28897689,,chr17,41243509,C,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
FLG-H2463D,FLG,"Tentatively evaluated as benign. Other, much more severe null mutations cause increased susceptibility ichthyosis vulgaris, atopic eczema, and allergies.",Low,Uncertain,Benign,0.0065,Immune system;Skin,Unknown,Heterozygous,,rs113188294,,chr1,152279975,C,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
ALK-L1033P,ALK,"Tentatively evaluated as nonpathogenic, although other disruptive variants are associated with familial neuroblastoma.",Low,Uncertain,Benign,0.0078,Cancer;Nervous system,Unknown,Heterozygous,,,,,,,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
PMS1-Y90Shift,PMS1,"This variant is tentatively evaluated as benign, as the only publications linking mutations in this gene to disease have been contradicted.",Low,Uncertain,Benign,0.0078,Other,Unknown,Heterozygous,11691795;14560016,,,,,,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
NOTCH3-P496L,NOTCH3,"Presumed benign, seen in two healthy PGP participants.",Low,Uncertain,Benign,0.016,Other,Unknown,Heterozygous,,rs11670799,,chr19,15299051,A,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
LRRK2-N2081D,LRRK2,"Reported as a rare, nonpathogenic variant.",Low,Uncertain,Benign,0.014,Other,Unknown,Heterozygous,15541309,rs33995883,,chr12,40740686,G,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
DCTN1-R1049Q,DCTN1,"Although rare and predicted to have a damaging effect, Vilarino-Guell et al. find the variant did not segregate with neurological disease and conclude it is not deleterious.",Low,Uncertain,Benign,0.0014,Nervous system,Unknown,Heterozygous,19506225,rs72659383,,chr2,74592252,T,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
COL7A1-P1277L,COL7A1,"Polymorphism, presumed benign.",Low,Uncertain,Benign,0.041,Other,Unknown,Heterozygous,,rs35761247,,chr3,48623124,A,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
TPCN2-G734E,TPCN2,Pigmentation allele.,Low,Uncertain,Benign,0.29,Other,Unknown,Homozygous,18488028,rs3829241,,chr11,68855363,A,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
CBLC-H405Y,CBLC,Probably benign.,Low,Uncertain,Benign,0.037,Other,Unknown,Heterozygous,19370762,rs3208856,,chr19,45296806,T,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Homozygous,12764676;19364639,rs2293869,,chr8,55539395,T,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
HTRA2-G399S,HTRA2,"Although one group reported this variant as being associated with Parkinson’s disease, their screen lacked statistical significance and later studies have found equal frequencies of this variant in unaffected controls. Knockout of this gene is reported to cause parkinsonianism in mice, but another functional study found no impact on the mitochondrial pathway they implicate as being causal in Parkinson’s.",Low,Uncertain,Benign,0.0036,Nervous system,Unknown,Heterozygous,15961413;18364387;19118185,rs72470545,0,chr2,74759825,A,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
GALT-N314D,GALT,"This variant has an allele frequency of ~8% and is ancestral to ""Duarte"" / ""Duarte 2"" and ""Duarte 1""/""Los Angeles"" galactosemia variants. This variant is evolutionarily ancestral, and in vitro studies fail to support an impact of this variant on enzyme activity. Carney et al. instead implicate a 4 base deletion on the 5' of the GALT gene as being causal and linked to this variant. Galactosemia is typically screened and detected in infants and causes early, severe but nonspecific symptoms (digestive problems, lethargy, failure to thrive).",Low,Uncertain,Benign,0.072,"Mouth, liver, and digestive",Unknown,Homozygous,10408771;11261429;19224951,rs2070074,,chr9,34649442,G,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
TYR-S192Y,TYR,This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).,Low,Uncertain,Benign,0.27,Skin,Unknown,Heterozygous,17952075;17999355,rs1042602,,chr11,88911696,A,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
FKTN-N446D,FKTN,Probably benign.,Low,Uncertain,Benign,0.009,Other,Unknown,Heterozygous,,rs41313301,,chr9,108397495,G,http://evidence.personalgenomes.org/genomes?display_genome_id=c210668f253dbc9d5c95e503ebb18a265ec5d1e3
